A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

NCT02140125 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Pharmacokinetics of ASP2408

Interventions

DRUG: ASP2408
DRUG: Placebo

Sponsor

Astellas Pharma Inc